Metal-Based Nanostructured Therapeutic Strategies for Glioblastoma Treatment—An Update
Glioblastoma (GBM) is the most commonly diagnosed and most lethal primary malignant brain tumor in adults. Standard treatments are ineffective, and despite promising results obtained in early phases of experimental clinical trials, the prognosis of GBM remains unfavorable. Therefore, there is need f...
Main Authors: | Agata M. Gawel, Ravi Singh, Waldemar Debinski |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/10/7/1598 |
Similar Items
-
Advances in Glioblastoma Therapy: An Update on Current Approaches
by: Ramcharan Singh Angom, et al.
Published: (2023-10-01) -
Exosomes: Novel Bio-Inspired Nanocarriers for Efficient Targeting of Glioblastoma Tumor Cells
by: V Taghdiri Nooshabadi, et al.
Published: (2021-03-01) -
Therapeutic and Diagnostic Potential of Exosomes as Drug Delivery Systems in Brain Cancer
by: Dimitrios I. Avgoulas, et al.
Published: (2023-05-01) -
Editorial: Functionalized Nanocarriers for Theranostics
by: Stefano Leporatti, et al.
Published: (2020-11-01) -
Nanotechnology-Based Combinatorial Anti-Glioblastoma Therapies: Moving from Terminal to Treatable
by: Amir Barzegar Behrooz, et al.
Published: (2022-08-01)